Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Bausch + Lomb has launched PreserVision Eye Vitamin and Mineral Supplement AREDS 2 formula in US. Bausch + Lomb said that the new formula builds on the original, clinically proven Age-Related Eye Disease Study (AREDS) formula, replacing beta-carotene with lutein (10mg) and zeaxanthin (2mg) and adding omega-3 fatty acids (1000 mg) per daily dosage.
Subscribe to our email newsletter
Bausch + Lomb said that PreserVision Eye Vitamin and Mineral Supplement AREDS 2 formula will be on retail shelves in early May, 2010.
Reportedly, scientific studies showed that the inclusion of high levels of omega-3 fatty acids, lutein and zeaxanthin in the diet supports eye health.
The AREDS2 study, which is currently ongoing and expected to complete in 2013, is sponsored by the National Eye Institute/National Institute of Health and is the second nationwide clinical study to determine whether a combination of vitamins and minerals can further slow the progression of vision loss from AMD.
According to Bausch + Lomb, PreserVision AREDS 2 formula is one of many formulas that are being evaluated in the study.
Bausch + Lomb’s core businesses include contact lenses and lens care products, ophthalmic surgical devices and instruments and ophthalmic pharmaceuticals.